Tower Wealth Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
Other funds holding MRK
VCM
VPM
Tower Wealth Partners's MRK Position: Q1 2026 in Review
Tower Wealth Partners reduced its Merck (MRK) stake by 34% in Q1 2026, selling an estimated $264K and leaving 4,524 shares worth $544K. The position accounts for 0.3% of the portfolio, ranked #38.
Tower Wealth Partners first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $976K in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Tower Wealth Partners held 4,524 shares of Merck worth $544K as of Q1 2026.
- Tower Wealth Partners sold 2,291 Merck shares in Q1 2026, an estimated $264K.
- Merck made up 0.3% of Tower Wealth Partners's portfolio in Q1 2026, its #38 holding.
- Tower Wealth Partners first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
- Tower Wealth Partners's Merck position peaked at $976K in Q2 2024.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Tower Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.